Macitentan
RxNorm 1442132
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1442132 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Macitentan.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Macitentan
(Atom ID: 12253151)
PTPrescribable
Designated preferred name (PT):
Macitentan
(Atom ID: 7263237)
FNPrescribable
Full form of descriptor (FN):
Macitentan (substance)
(Atom ID: 7263238)
PTPrescribable
Designated preferred name (PT):
Macitentan-containing product
(Atom ID: 10806352)
FNPrescribable
Full form of descriptor (FN):
Product containing macitentan (medicinal product)
(Atom ID: 10307681)
Patient Education
Macitentan
Macitentan is used to manage the symptoms of pulmonary arterial hypertension (PAH; high blood pressure in the vessels that carry blood to the lungs). Macitentan is in a class of medications called endothelin receptor antagonists. It works by stopping the action of endothelin, a natural substance that causes blood vessels to narrow and prevents normal blood flow in people who have PAH.
[Learn More]
* Please review the disclaimer below.